Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-20

Clinical Trial Update: The Effect of a Novel Blueberry Supplement on Dry Eye Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing a novel blueberry supplement for dry eye disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Blueberry supplement (novel)

Snippet

Sponsor: SightSage Foods and Nutrition Inc. | Conditions: Dry Eye | Phase 3 | Status: COMPLETED